histoplasmin.
However, in a paper published in May 1947, Howell (2) continued the experimental work of Emmons, and came to different conclusions. He utilized three lots of histoplasmin, five of blastomycin, and heat-killed antigens prepared from yeast cultures of these two fungi. His protocols show that the number of guinea pigs experimentally infected with Blastomyces or Histoplasma which react to these antigens depends upon the "particular lot of antigen employed and upon the dilution of this particular lot." He found that there is an initial titer for each antigen which gives positive reactions in about 90 per cent of animals infected with the homologous fungus, and less than 10 per cent of cross reactions. Also, "the level or degree of sensitivity of the animals employed to determine the titer of an antigen must be considered. That is, if the sensitivity level is low, a high concentration of the antigen will have to be used to elicit a reaction, and therefore a false impression of the initial titer of the antigen will be obtained. Such high concentrations of antigen will produce a high percentage of cross reactions."
In a clinical study in Tennessee, Christie and Peterson (3) found no false positive coccidioidin skin reactions in children and young adults. In this region coccidioidomycosis has not yet been reported. Of 125 individuals tested, many reacted definitely to histoplasmin, but none to coccidioidin. C. E. Smith (4) stated that coccidioidin is generally specific but occasionally may give false positive reactions in patients with other systemic mycoses. Martin (5) noted that blastomycin produces no false positive skin reactions though it may give a false negative reaction in a patient with a generalized infec-tion. Butt and Hoffman (6) found no cross-sensitivity to blastomycin and sporotrichin in 8 patients with positive coccidioidin reactions. They also found 18 additional individuals with negative reactions to all 3 antigens.
It thus appears from a survey of the available literature that there is much cross-sensitization experimentally and clinically between histoplasmin and blastomycin, but coccidioidin is relatively specific. Because of the still unsettled nature of this problem, we wish to add the results of skin tests made on 36 patients suspected of infection with a deep mycosis.
SKIN TESTING MATERIAL
Blastomycin, coccidioidin, histoplasmin, and sporotrichin were furnished by Conant and Callaway of Duke University Medical School. Their antigen is a saline suspension of the heat-killed fungus culture "diluted in sufficient saline to give the vaccine the density of a light ground-glass appearance" (7) . Keeney 
TECHNIC
One-tenth of a cubic centimeter of one or more of the antigens was injected intradermally on the volar surface of the forearm. The test was read alter 24 and 48 hours, and in many instances after 7 days. A positive reaction consisted of an inflammatory papule of at least 7 mm. in diameter. It was noted in 24 hours in all instances except 1, patient number 1, when it did not appear until 7 days after the injection.
NEGATIVE REACTIONS
Of the 36 patients tested, 24 showed entirely negative reactions (47 tests). The distribution of these patients yielding negative reactions is indicated in Table 1 . Twelve patients showed positive skin reactions to one or more of the antigens. The details of these positive reactors are shown in Table 2 .
COMMENT
Of the 24 entirely negative reactors, only one patient, who later died, was proved to have had a systemic mycosis. All 4 antigens gave negative reactions just one week before death, and at autopsy, widespread histoplasmosis was found. This anergic state when the disease is far advanced is well known (9) .
Including this one false negative result, the 47 negative reactions on 24 patients may well serve as controls for the patients with positive reactions. They suggest that the antigens are not primary irritants and probably produce no false-positive reactions in individuals not suffering from a systemic fungus disease.
Among the 12 positive reactors on whom a total of 38 tests were done, 5 instances of cross-sensitization were noted. Three patients probably infected with histoplasmosis with a positive histoplasmin test, also reacted in a positive manner to blastomycin. The patient with chromoblastomycosis also gave a positive reaction to blastomycin as did the patient with sporotrichosis who had a positive sporotrichin test. So, in this small series of cases, blastomycin was the only antigen which showed evidence of cross-sensitivity.
From my results it is impossible to evaluate the specificity and sensitivity of the antigen which is a saline suspension of the heat-killed fungus culture, as compared with the antigen which is a sterile broth filtrate of the fungus culture.
In further studies it will be desirable to standardize these antigens either by quantitative nitrogen determinations or by intradermal injections of serial dilutions in infected guinea pigs.
The cross-sensitization between histoplasmin and blastomycin suggests the possibility of their having a common antigen either in the polysaccharide or protein fraction. Further experimental and clinical testing would be necessary to evaluate this supposition.
SiJMMAIIY
From skin tests with histoplasmin coccidioidin, blastomycin, and sporotrichin on 36 patients, the following conclusions are drawn:
1. These antigens in the dilutions noted are not primary irritants and probably give no false-positive reactions in individuals with no deep mycosis.
2. In a small series of 12 positive reactors, cross-sensitization occurred only with blastomycin. This tends to confirm the results obtained by previous workers who found that there was cross-sensitization between histoplasmin and blastomycin, but that none developed in the use of coccidioidin or sporotrichin.
3. Suggestions are made for further studies which might explain this phenomenon.
DISCUSSIONS
Dr. Harold C. Fishman: During an Army assignment in the San Joaquin Valley in 1945, I had the opportunity to study several hundred cases of coccidioidomycosis with Dr. Charles E. Smith. They were all skin tested with coccidioidin, and most of them also with histoplasmin. Well over 60 per cent of the patients with proven coccidioidomycosis also gave a positive skin test with histoplasmin, although usually to a lesser degree than with cocciclioidin.
Dr. Leslie Smith: We have been very much interested in this subject, have done some work and are very very glad to see that somebody else has had the opportunity to study the problem. It has been our practice to test all patients with suspected deep mycoses simultaneously on the arm, at the same time, with sporotrichin, blastomycin and coccidioidin, because these happen to be our most common deep mycoses. On the whole the tests have been fairly specific, although not entirely so. We have had some cross reactions. I think it important in regard to coccidioidomycosis that we consider the frequency in certain parts of the country of positive reactions to coccidioidin in apparently healthy individuals. In various parts of Texas, Arizona, California, in particular, a good many positive reactions have been found in the Service among people who were not supposed to have deep mycoses. We do not think this is a false positive reaction. The acute pulmonary form of coccidioidomycosis is apparently more common than most of us have been led to believe, -a number of cases have been found in the Southwest, particularly in California. Once the test becomes positive it is likely to remain so. I have an idea that study in other parts of the country might possibly reveal something similar, though to a lesser extent. There have been cases of acute pulmonary coccidioidomycosis reported sporadically from other parts of the country and I think the positive reaction should have consideration from that angle.
Dr. Lawrence Katzenstein: The whole problem of who is infected with histoplasmosis and the particular significance of the histoplasmin skin test is undecided. Palmer (10) found instances varying from 4 to 61 per cent of positive reactors among nurses in five different cities. One way to attack the problem is to use antigens which are standardized on animals so one knows their titre. Using these antigens it may be possible to evaluate infected on non-infected individuals.
Note: I am greatly indebted to the donors of the antigens; also to the Pediatric, Medical, and Ophthalmologic Services of the Hospital of the University of Pennsylvania; the Dermatologic Service of the Graduate Hospital of the University of Pennsylvania; Dr. David Cooper and Dr. Elizabeth Constant of Philadelphia, Pa.; and Dr. Jacob Schildkraut of Trenton, N. J. for the use of their patients in this study.
